Burcon Nutrascience Corporation Achieves Key Milestones in Plant-Based Protein Market
TL;DR
Burcon Nutrascience's rapid scale-up of pea protein production and strategic partnerships positions it to capitalize on a market with a TAM of US$215M to US$392M.
Burcon Nutrascience achieved commercial production of pea protein isolate in under 90 days, optimizing its capital structure through a 20:1 share consolidation and securing a capital-light production facility via ProMan partnership.
Burcon Nutrascience's advancements in plant-based proteins, including pea and canola proteins, contribute to sustainable food solutions, aligning with global health and environmental goals.
Burcon Nutrascience innovates with Peazazz® pea protein and Puratein® canola protein, launching Solatein™ sunflower protein isolate, marking significant strides in plant-based protein technology.
Found this article helpful?
Share it with your network and spread the knowledge!
Burcon Nutrascience Corporation (TSX: BU) has reached a pivotal milestone by scaling up commercial production of its pea protein isolate at its Galesburg facility, a move that significantly enhances its market position. This development, achieved in less than 90 days, enables Burcon to meet growing customer demand and capitalize on revenue opportunities in a market with a total addressable market (TAM) estimated between US$215M and US$392M.
The company has also announced a share consolidation program at a 20:1 ratio, set to commence on June 11, 2025, aimed at optimizing its capital structure. Additionally, Burcon's strategic partnership with ProMan to acquire and operate a protein production facility underscores its commitment to maintaining a capital-light position while securing full control over the production of its plant-based protein products. This partnership is expected to contribute significantly to Burcon's revenue, with projections of $1M to $3M in the first year and over $10M by the second year.
Burcon's collaboration with Puratos to explore new canola protein applications and the launch of next-generation Peazazz® pea protein and Puratein® canola protein for egg replacement applications highlight the company's innovation in the plant-based protein sector. The successful closure of a rights offering, raising $9.43M in gross proceeds, further strengthens Burcon's financial position, ensuring liquidity for future operations.
Financially, Burcon reported a net loss of $1.8M in 3Q25, an improvement from the $2.0M loss in the same period last year, with revenues from protein isolate sales and contract research services marking a positive shift from no revenue in the previous year. The company's strategic initiatives and financial maneuvers are poised to drive growth and profitability, with positive cash flows anticipated by FY26.
Curated from Reportable
